Pharmacological, toxicological and neurochemical effects of Δ2(E)-valproate in animals
- 1 June 1992
- journal article
- review article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 14 (3) , 139-143
- https://doi.org/10.1007/bf01962705
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Neurotransmitters and shaking behaviour — more than a ‘gut-bath’ for the brain?Trends in Pharmacological Sciences, 1986
- Is amygdala kindling in rats a model for drug-resistant partial epilepsy?Experimental Neurology, 1986
- Pharmacologic evaluation of various metabolites and analogs of valproic acid: Teratogenic potencies in miceFundamental and Applied Toxicology, 1986
- Transfer of valproic acid and its main active unsaturated metabolite to the gestational tissue: Correlation with neural tube defect formation in the mouseTeratology, 1986
- Valproic acid and active unsaturated metabolite (2-EN): Transfer to mouse liver following human therapeutic dosesBiopharmaceutics & Drug Disposition, 1985
- Valproic Acid and Metabolites: Pharmacological and Toxicological StudiesEpilepsia, 1984
- Alterations in CSF GABA levels and seizure susceptibility developing during repeated administration of pentetrazole in dogs. Effects of γ-acetylenic GABA, valproic acid and phenobarbitalNeurochemistry International, 1983
- Valproate–Induced Hepatic Steatogenesis in RatsHepatology, 1982
- Effect of metabolites of valproic acid on the metabolism of GABA in brain and brain nerve endingsNeuropharmacology, 1981
- Effect of valproic acid on serotonin metabolismNeuropharmacology, 1979